Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Allos begins enrollment for phase I study of PDX with vitamin B12 and folic acid

Aug. 20, 2007

Several series of protein kinase inhibitors claimed for the treatment of cancer

Aug. 20, 2007

Recruitment completed for pSivida phase IIa study of BrachySil

Aug. 16, 2007

Genta announces initiation of Genasense named-patient/compassionte program

Aug. 16, 2007

PRLX-93936's antitumor activity profiled by Prolexys

Aug. 16, 2007

Cytopia achieves primary objectives of phase I trial for i.v. anticancer agent

Aug. 14, 2007

Nereus Phamaceuticals will use stock gains to develop cancer therapies

Aug. 14, 2007

Anadis plans clinical study of polyclonal antibodies

Aug. 14, 2007

IND for Active Biotech's phase II study of TASQ approved by FDA

Aug. 13, 2007

Patient enrollment begins for ImClone's phase II study of IMC-11F8

Aug. 13, 2007

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...